Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 286-302
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286
Prognostic variables | Number | Expression of CIP2A | χ2 | P value | |
Low | High | ||||
Sex | 1.766 | 0.184 | |||
Male | 71 | 27 | 44 | ||
Female | 37 | 19 | 18 | ||
Age, yr | 0.175 | 0.676 | |||
< 60 | 68 | 30 | 38 | ||
≥ 60 | 40 | 16 | 24 | ||
Tumor location | 0.097 | 0.756 | |||
Proximal + middle | 37 | 15 | 22 | ||
Distal | 71 | 31 | 40 | ||
Histological grade | 0.001 | 0.973 | |||
G1 + G2 | 26 | 11 | 15 | ||
G3 | 82 | 35 | 47 | ||
Tumor size in cm | 5.975 | 0.015a | |||
< 5 | 84 | 41 | 43 | ||
≥ 5 | 24 | 5 | 19 | ||
T stage | 5.472 | 0.019a | |||
T1–T2 | 36 | 21 | 15 | ||
T3–T4 | 72 | 25 | 47 | ||
N stage | 12.428 | 0.000a | |||
N0 | 47 | 29 | 18 | ||
N1–N3 | 61 | 17 | 44 | ||
TNM stage | 5.168 | 0.023a | |||
I + II | 69 | 35 | 34 | ||
III + IV | 39 | 11 | 28 |
Prognostic variables | Univariate analysis | Multivariate analysis | ||||
Hazard ratio | 95% confidence interval | P value | Hazard ratio | 95% confidence interval | P value | |
Sex | 0.99 | 0.584–1.679 | 0.97 | - | - | - |
Age | 1.372 | 0.820–2.296 | 0.229 | - | - | - |
Tumor location | 0.925 | 0.545–1.569 | 0.772 | - | - | - |
Histological grade | 0.736 | 0.420–1.288 | 0.283 | - | - | - |
Tumor size | 2.417 | 1.399–4.176 | 0.004a | 0.87 | 0.504–1.504 | 0.619 |
T stage | 3.184 | 1.687–6.007 | 0.000a | 2.651 | 1.295–5.423 | 0.008a |
N stage | 2.034 | 1.196–3.457 | 0.009a | 1.414 | 0.709–2.818 | 0.325 |
TNM stage | 1.946 | 1.168–3.243 | 0.011a | 0.912 | 0.469–1.774 | 0.786 |
CIP2A expression | 2.319 | 1.288–3.927 | 0.003a | 1. 802 | 1.012–3.210 | 0.046a |
Prognostic variables | Univariate analysis | Multivariate analysis | ||||
Hazard ratio | 95% confidence interval | P value | Hazard ratio | 95% confidence interval | P value | |
Sex | 0.973 | 0.574–1.650 | 0.919 | - | - | - |
Age | 1.363 | 0.814–2.281 | 0.239 | - | - | - |
Tumor location | 0.913 | 0.538–1.548 | 0.735 | - | - | - |
Histological grade | 0.73 | 0.417–1.278 | 0.27 | - | - | - |
Tumor size | 2.43 | 1.407–4.197 | 0.004a | 0.869 | 0.504–1.499 | 0.614 |
T stage | 3.15 | 1.669–5.943 | 0.000a | 2.644 | 1.294–5.420 | 0.009a |
N stage | 2.044 | 1.202–3.476 | 0.008a | 1.451 | 0.728–2.891 | 0.29 |
TNM stage | 1.917 | 1.150–3.194 | 0.013a | 0.88 | 0.452–1.713 | 0.88 |
CIP2A expression | 2.309 | 1.282–3.911 | 0.003a | 1.821 | 1.021–3.247 | 0.042a |
- Citation: Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2023; 15(2): 286-302
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/286.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.286